Angela Weyand/medschool.umich.edu
Jul 22, 2026, 14:31
What Could Shape the Future of Hemophilia A Care? – Novo Nordisk Medical US
Novo Nordisk Medical US shared a post on X:
“Thank you to everyone who connected with us at ISTH26!
Hear Dr. Angela Weyand discuss her key takeaways from this year’s meeting and what they could mean for the future of hemophilia A care.
Discover ISTH resources from Novo Nordisk.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 22, 2026, 17:17Storage Pool Deficiency An Overview of a Rare Platelet Disorder – EHC
-
Oct 22, 2026, 17:10Matthew Hazell: Optimizing the Use of Rare Red Blood Cell Units
-
Oct 22, 2026, 17:03Smita Patil: New Insights Into Platelet Alpha-Granule Secretion
-
Oct 22, 2026, 16:48Ahmed Alotaibi: Rare Rh Phenotype and Severe Fetal Anaemia
-
Oct 22, 2026, 16:36Alissa Odum: Every Blood Type Matters Every Donation Saves Lives
-
Oct 22, 2026, 16:33Mehul Malhotra: Targeted Therapies and Clinical Advances Transform the wAIHA Treatment Landscape
-
Oct 22, 2026, 16:13William Wallace: The Hidden Neurological Impact of Vitamin B12 Deficiency
-
Oct 22, 2026, 16:06Akram Farhadi: Anemia and Low Hemoglobin Associated With Higher Risk of Osteosarcopenia in Older Adults
-
Oct 22, 2026, 15:49Javed Iqbal: NUMC Pulmonary and Critical Care Team Showcases Research at CHEST 2026